Biopsy Needles: Market Size & Forecast 2026

The global biopsy needles market sits at approximately USD 650 million in 2025 (base year), structurally anchored by oncology demand growth, regulated supply constraints in precision machining, and persistent category-wide shortages of specific gauge configurations that have driven hospital procurement teams to maintain elevated safety stock levels through mid-2026. > **Analyst Take.** The call is this: the 22 Gauge breast biopsy shortage is not a temporary disruption. It reflects a structural single-source dependency that will take 18, 24 months to work through even if new capacity is announced tomorrow. Buyers who use the current shortage as leverage to renegotiate with BD and Hologic will find those conversations going nowhere. The right move is to qualify IZI Medical and other mid-tier suppliers aggressively, accept a modest price premium for dual-sourced cover, and treat the current

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.